Index | MSCI Europe |
Investment focus | Equity |
Fund size | GBP 110 m |
Total expense ratio | 0.12% p.a. |
Replication | Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | - |
Inception/ Listing Date | 20 March 2024 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 31 October |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | Unknown |
Switzerland | Unknown |
Austria | Unknown |
UK | Unknown |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Novo Nordisk | 3.75% |
ASML Holding | 3.50% |
Nestle | 2.56% |
LVMH Moet Hennessy | 2.24% |
Shell | 1.94% |
AstraZeneca | 1.88% |
SAP | 1.83% |
Novartis | 1.79% |
Roche Holding | 1.61% |
HSBC Holdings | 1.35% |
YTD | - |
1 month | +2.54% |
3 months | - |
6 months | - |
1 year | - |
3 years | - |
5 years | - |
Since inception (MAX) | +2.54% |
2023 | - |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | - |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | - |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -2.76% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
XETRA | EUR | CEBZ | - - | - - | - |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core MSCI Europe UCITS ETF EUR (Dist) | 7,747 | 0.12% p.a. | Distributing | Sampling |
iShares Core MSCI Europe UCITS ETF EUR (Acc) | 7,334 | 0.12% p.a. | Accumulating | Sampling |
Xtrackers MSCI Europe UCITS ETF 1C | 4,056 | 0.12% p.a. | Accumulating | Full replication |
Amundi Index ETF MSCI Europe UCITS ETF DR (C) | 1,882 | 0.15% p.a. | Accumulating | Full replication |
Amundi MSCI Europe II UCITS ETF Acc | 784 | 0.25% p.a. | Accumulating | Full replication |